. 2006 Dec 20;81(6):2713–2725. doi: 10.1128/JVI.01830-06

TABLE 1.

Patient characteristics: cross-sectional cohort

Group and patient no.	Peripheral blood CD4⁺ T-cell count (cells/μl)^a	Plasma HIV RNA (copy equivalents/ml)^a	Therapy^b
LTNP
49	1,301	<50
53	825	<50
38	1,588	<50
34	1,030	<50
17	950	<50
4	1,333	<50
33	1,048	<50
37	958	<50
On therapy
129	482	<50	ZDV, 3TC, NEL
113	574	<50	ZDV, 3TC, NEL
130	387	<50	ZDV, 3TC, ABC
114	249	<50	TDF, EFV, RTV, APV
242	784	<50	3TC, d4T, IND
208	889	<50	ZDV, 3TC, IND, RTV
128	1,125	<50	ZDV, 3TC, IND
Off therapy
44	893	20,940
15	738	540
21	15	55,862
147	811	27,855
137	321	29,215
146	784	213,759
148	403	74,940
108	249	61,209

Values shown were obtained at the time of apheresis.

ZDV, zidovudine; d4T, stavudine; NEL, nelfinavir; 3TC, lamivudine; IND, indinavir; RTV, ritonavir; EFV, efavirenz; TDF, tenofovir; ABC, abacavir; APV, amprenavir.